ERBB2 and breast carcinoma: The immunohistochemical reaction for the markers, which are routinely investigated in colorectal (CEA, CK20) and breast cancers (ER, PgR, Ki67 and HER2) gave results indistinguishable from those obtained from the samples of the same cases processed by standard method.